Elanco Animal Health (ELAN) Leases (2018 - 2025)

Elanco Animal Health has disclosed Leases across 8 years of filings, most recently posting $226.0 million for Q4 2025.

• Leases for Q4 2025 came in at $226.0 million, up 85.25% year-over-year; the trailing twelve-month figure through Dec 2025 was $226.0 million (up 85.25% YoY), and the FY2025 annual result was $226.0 million, up 85.25% from the prior year.
• Leases came in at $226.0 million for Q4 2025 at Elanco Animal Health, up from $122.0 million in the prior quarter.
• In the past five years, Leases ranged from a high of $226.0 million in Q4 2025 to a low of $122.0 million in Q4 2024.
• The 5-year median for Leases is $141.0 million (2022), against an average of $158.0 million.
• Across the five-year window, Leases declined 13.9% in 2021 and jumped 85.25% in 2025, its largest moves.
• Elanco Animal Health's Leases stood at $161.0 million in 2021, then slipped by 12.42% to $141.0 million in 2022, then fell by 0.71% to $140.0 million in 2023, then declined by 12.86% to $122.0 million in 2024, then soared by 85.25% to $226.0 million in 2025.
• The last three Leases figures came in at $226.0 million (Q4 2025), $122.0 million (Q4 2024), and $140.0 million (Q4 2023), per Business Quant data.